DGNOF — Diagnos Inc.

—
OTC · Unknown · Unknown · CIK 1790693 ·
Last close
$0.22
Market Cap
$26.14M
52W High
$0.38
52W Low
$0.13
ADV30
72,583
Next earnings
2026-11-18

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Mar 2026 15,711 1,144,830 -1,138,304 -1,184,461 2,390,530 310,012 1,703,633
Dec 2025 15,206 -401,965 -1,067,631 -1,161,114 3,903,839 394,926 2,407,925
Sep 2025 15,159 -360,421 -990,301 -1,096,342 1,172,191 490,593 2,709,543
Jun 2025 19,402 -372,430 -1,033,416 -1,113,282 2,053,009 118,251 2,854,743

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-3,753,516
Investing CF
$1,561,896
Financing CF
$2,412,255
CapEx
$-11,061
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-0.03
As of
2026-10-18

Balance + Analyst (yfinance extras)

Retained Earnings
$-59,488,590
Inventory
—
Receivables
$194,862
ST Investments
$1,616,779
EBIT TTM
$-4,166,658
Pretax Income TTM
$-4,555,199
Interest Exp TTM
$388,541
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$65,478
EBITDA
$-4,250,006
Free Cash Flow
$-2,465,934
Enterprise Value
$40,403,080
Total Cash
$1,926,791
Total Debt
$1,401,646
Shares Out
121,037,549
Trailing EPS
$-0.03
Book Value
$0.00
ROE
-990.3%
ROA
-88.4%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Mar 2026 65,478 -4,249,927 -4,555,199 2,390,530 1,703,633 686,897 -3,753,516
Mar 2025 103,797 -3,811,093 -4,286,449 3,636,104 3,402,994 233,110 -3,637,452
Mar 2024 170,158 -2,590,707 -3,120,582 663,787 3,715,635 -3,051,848 -2,147,432
Mar 2023 485,749 -2,221,672 -2,480,816 823,031 2,771,238 -1,948,207 -1,883,811
Mar 2022 — — — — — — —

Peers — same industry

TickerNameMarket CapLastDaily %
TTIPF Thiogenesis Therapeutics, Corp. $26.15M $0.37 —
CYDVF Century Lithium Corp. $26.03M $0.14 —
SPMEF South Pacific Metals Corp. $26.01M $0.37 —
HERZ Herzfeld Credit Income Fund, Inc $26.33M $13.10 —
LASE LASE Corp. $25.90M $0.43 —

News headlines (Yahoo Finance, 1h cache)

DIAGNOS Accelerates Nationwide Deployment of Its CARA System Solution Licensed by Health Canada Following the Successful Installation of a First Group of Optometry Clinics
2026-10-20 13:00 · Yahoo
DIAGNOS Provides an Update on Stock Warrants
2026-10-06 14:35 · Yahoo
DIAGNOS Advances Regulatory Strategy with US FDA Submission for CARA System
2026-09-28 15:56 · Yahoo
Presenting on Emerging Growth Conference 96 Day 1 on September 23; Register to live stream
2026-09-22 11:00 · Yahoo
DIAGNOS to Hold its Annual General Meeting of Shareholders on September 30, 2026
2026-09-14 16:41 · Yahoo
DIAGNOS Receives Saudi FDA Medical Device License for CARA System, Bringing AI-Assisted Retinal Image Analysis to Saudi Arabia
2026-08-13 18:21 · Yahoo
DIAGNOS Receives Health Canada Medical Device Licence for CARA System, Bringing AI-Assisted Retinal Image Analysis to Canadian Optometrists
2026-07-27 19:20 · Yahoo
Presenting on Emerging Growth Conference 94 Day 1 on July 15; Register to live stream
2026-07-14 11:00 · Yahoo
DIAGNOS to Extend the Exercise Period of Stock Warrants
2026-07-07 16:38 · Yahoo
DIAGNOS Announces Shares for Debt Settlement
2026-06-18 16:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.